GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Soiken Holdings Inc (TSE:2385) » Definitions » EPS (Diluted)

Soiken Holdings (TSE:2385) EPS (Diluted) : 円-23.66 (TTM As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Soiken Holdings EPS (Diluted)?

Soiken Holdings's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was 円-3.31. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was 円-23.66.

Soiken Holdings's EPS (Basic) for the three months ended in Mar. 2024 was 円-3.31. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was 円-23.66.

Soiken Holdings's EPS without NRI for the three months ended in Mar. 2024 was 円-3.31. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was 円-23.66.

During the past 12 months, Soiken Holdings's average EPS without NRIGrowth Rate was -192.90% per year. During the past 3 years, the average EPS without NRIGrowth Rate was -14.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 15.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Soiken Holdings's highest 3-Year average EPS without NRI Growth Rate was 109.50% per year. The lowest was -290.80% per year. And the median was 27.20% per year.


Soiken Holdings EPS (Diluted) Historical Data

The historical data trend for Soiken Holdings's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Soiken Holdings EPS (Diluted) Chart

Soiken Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.16 27.97 21.49 30.95 17.27

Soiken Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.97 -1.70 -20.15 1.50 -3.31

Competitive Comparison of Soiken Holdings's EPS (Diluted)

For the Biotechnology subindustry, Soiken Holdings's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Soiken Holdings's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Soiken Holdings's PE Ratio distribution charts can be found below:

* The bar in red indicates where Soiken Holdings's PE Ratio falls into.



Soiken Holdings EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Soiken Holdings's Diluted EPS for the fiscal year that ended in Jun. 2023 is calculated as

Diluted EPS (A: Jun. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(451.847-0)/26.158
=17.27

Soiken Holdings's Diluted EPS for the quarter that ended in Mar. 2024 is calculated as

Diluted EPS (Q: Mar. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-86.646-0)/26.158
=-3.31

EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-23.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Soiken Holdings  (TSE:2385) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Soiken Holdings EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Soiken Holdings's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Soiken Holdings (TSE:2385) Business Description

Traded in Other Exchanges
N/A
Address
1-4-2 Shinsenri-Higashimachi, 13th Floor, Senri Life Science Center, Toyonaka, Osaka, JPN, 560-0082
Soiken Holdings Inc operates as a biotechnology company in Japan. It provides clinical testing for pharmaceutical and food manufacturers that develop drugs and health food products based on biomarkers. It is involved in the marketing research and post-marketing surveillance of health supplements.

Soiken Holdings (TSE:2385) Headlines

No Headlines